Sonoma Biotherapeutics Announces Oral and Poster Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting

On May 6, 2025 Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, reported that it will be sharing oral and poster presentations at the American Society of Gene and Cell Therapy (ASGCT) (Free ASGCT Whitepaper) 28th Annual Meeting, taking place in New Orleans May 13-17, 2025 (Press release, Sonoma Biotherapeutics, MAY 6, 2025, View Source [SID1234652613]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

"We are excited to share data demonstrating the promise of Treg-based cell therapies at this year’s ASGCT (Free ASGCT Whitepaper) Annual Meeting," said Jeff Bluestone, Ph.D., Chief Executive Officer and President of Sonoma Biotherapeutics. "Sharing the latest insights on the potential impact this research can have in autoimmune diseases is a privilege for all of us at Sonoma Biotherapeutics."

Details of the presentations are as follows:

Scientific Symposium Oral Presentation Details:

Title: "Engineered Treg therapies to treat Autoimmune Diseases"
Presenting Author: Jeff Bluestone, PhD, Sonoma Biotherapeutics
Session: Expanding Modalities Beyond Their Initial Use: Discussions on Translating Immune Cell Therapies into Non-Oncology Indications
Date/Time: Saturday May 17, 8:00 – 9:45 a.m. PDT
Location: Room 293-296
Oral Presentation Details:

Title: "Transcriptomic and Epigenomic Analysis of CAR Treg Stability"
Presenting Author: Zhang "Frank" Cheng, PhD, Sonoma Biotherapeutics
Session: Cell Therapy Product Engineering I
Date/Time: Wednesday May 14, 8:30 – 9:45 a.m. PDT
Location: Room 293-296
Poster Presentation Details:

Title: "Treg Specific Synthetic Promoters (TRSP) for Antigen Specific Treg Therapy"
Presenting Author: Jia Wei, PhD, Sonoma Biotherapeutics
Poster number: 1764
Session: Poster Reception
Date/ Time: Thursday, May 15, 5:30 – 7:00 p.m. PDT
Location: Poster Hall 2